Understanding Melanoma: The ABCDEs of Skin Cancer Detection
The ABCDE rule gives you a structured way to examine moles for melanoma warning signs. Dr. Mohsen Khoddami explains each letter and what to do if a mole concerns you.
As of August 20, 2024.
Melanoma is one of the most serious forms of skin cancer, yet it is also one of the most detectable when you know what to look for. The ABCDE (Asymmetry, Border, Color, Diameter, Evolving) rule gives patients and clinicians a practical framework for identifying suspicious moles during routine skin checks. This article explains each letter, outlines what a normal mole looks like by comparison, and tells you when to seek a dermatologist's assessment.
If you are looking for faster access to a certified dermatologist in Canada, DermaDex connects patients with specialists and provides AI (Artificial Intelligence)-assisted triage to help you get answers sooner.
What is the ABCDE rule for melanoma?
Short answer: The ABCDE rule is a five-point checklist used to identify physical warning signs of melanoma during a skin cancer self check. Each letter stands for one criterion: Asymmetry (one half does not match the other), Border irregularity (ragged or notched edges), Color variation (multiple shades in one spot), Diameter over 6 mm, and Evolving appearance (changes over time). Dermatologists and the American Academy of Dermatology (AAD) melanoma skin cancer types page have promoted this framework since the 1980s to standardize public education on melanoma warning signs. A benign mole typically stays the same shape and color for years. A melanoma tends to change, and the ABCDE rule captures the most common ways that change appears. It does not replace a clinical skin exam, but it gives patients a consistent method for self-monitoring that can prompt earlier medical review.
How do you apply the ABCDE rule to a mole?
Short answer: You examine each mole against all five criteria. One positive finding is a reason to book a dermatology appointment. Multiple findings increase the urgency, and any mole that bleeds or changes rapidly warrants same-week attention rather than a routine referral.
The table below describes each letter in concrete, visual terms so you can compare what you see on your own skin.
| Letter | Stands For | Benign Mole | Melanoma Warning |
|---|---|---|---|
| A | Asymmetry | Both halves match when you draw a line through the center | One half looks visibly different from the other |
| B | Border | Smooth, clearly defined edge | Ragged, notched, scalloped, or blurred edge |
| C | Color | Single, consistent shade of brown or tan | Multiple shades: dark brown, black, red, white, or blue within the same spot |
| D | Diameter | Smaller than 6 mm (roughly the size of a pencil eraser) | 6 mm or larger, though early melanomas can be smaller |
| E | Evolving | Stays the same size, shape, and color over months | Changes in size, shape, color, or texture; new bleeding or crusting |
Check every mole on your body, including areas not normally exposed to sun: the scalp, between toes, and under nails. Use a full-length mirror and a hand mirror for hard-to-see spots.
What is the 7 point checklist for melanoma?
Short answer: The 7 point checklist is a clinical scoring tool developed at the University of Glasgow that adds features such as oozing, inflammation, and altered sensation to the ABCDE criteria. A score of 3 or more on this tool indicates referral for specialist assessment. It is more common in UK primary-care practice than in Canada, where the ABCDE framework remains the standard taught to patients.
The 7 point checklist divides findings into major and minor categories. Major features score 2 points each: change in size, irregular pigmentation, and irregular border. Minor features score 1 point each: inflammation, oozing or bleeding, change in sensation such as itch or tingling, and diameter of 7 mm or more. The ABCDE rule and the 7 point checklist are complementary tools. For patient self-checks, ABCDE is more widely taught in Canada and the United States. The Canadian Dermatology Association (CDA) includes ABCDE-based materials in its patient education resources distributed to primary-care providers. If a mole scores 3 or more on the 7 point checklist, or meets any ABCDE criterion, contact a dermatologist promptly.
Is ABCDE enough to detect melanoma?
Short answer: The ABCDE rule identifies the majority of common melanomas but misses certain subtypes, including amelanotic melanoma (which lacks pigmentation) and acral lentiginous melanoma (which appears on palms, soles, and under nails). It works best as a monthly self-monitoring habit, not a standalone diagnostic test, and should be paired with annual professional skin exams.
Research indexed in PubMed shows that ABCDE criteria carry strong sensitivity for superficial spreading melanoma, the most common subtype. However, amelanotic melanomas look like a pink or skin-colored bump and do not trigger the standard color or asymmetry alerts. Acral lentiginous melanomas can also present atypically under the ABCDE framework. For this reason, the AAD recommends a full professional skin examination once per year for adults with a personal or family history of skin cancer, and once per month self-exams for everyone. If you notice anything that does not look right, even if it does not fit the ABCDE criteria, book a dermatology appointment. Access to a dermatologist in Canada can involve long wait times; DermaDex's About page explains how we are working to shorten that gap.
What causes melanoma and who is at risk?
Short answer: Ultraviolet (UV) radiation from the sun and tanning beds is the primary driver of melanoma, causing DNA damage in the pigment-producing melanocyte cells. Risk increases with fair skin, a history of sunburns, many moles, a family history of melanoma, and use of indoor tanning equipment.
UV radiation is classified into two main bands: ultraviolet A (UVA), which penetrates deep into the dermis, and ultraviolet B (UVB), which primarily affects the outer skin layers and causes sunburn. Both bands damage DNA in melanocytes. The World Health Organization (WHO) ultraviolet radiation fact sheet classifies solar radiation as a Group 1 carcinogen and attributes approximately 86% of melanoma cases to UV exposure. Key risk factors include: fair or light skin, red or blond hair, and blue or green eyes; a history of blistering sunburns especially in childhood; more than 50 common moles or any atypical (dysplastic) moles; a family history of melanoma in a first-degree relative; a personal history of any previous skin cancer; a weakened immune system; and use of indoor tanning equipment. In Canada, melanoma incidence has increased steadily over the past two decades according to Statistics Canada data.
How do you perform a skin cancer self check?
Short answer: A thorough self-exam takes about 10 minutes and covers the entire body surface using two mirrors and good lighting. The CDC skin cancer basics page recommends performing it once per month, ideally after a shower, to build familiarity with your skin so you notice new growths or changes quickly.
Step through your body in a consistent order each time. Start with your face, ears, neck, and scalp. Raise your arms and check both sides of your torso, including the skin under your arms. Examine the front and back of your legs, including the backs of your knees. Use a hand mirror to check your back and buttocks. Sit down and inspect your feet, including between the toes and the soles. Check under your fingernails and toenails for dark streaks. Part your hair section by section and check your scalp with a comb. The goal is to build a mental map of your skin so you notice changes, not to diagnose anything. Photograph moles you are monitoring so you can compare over time. If you find something that meets one or more ABCDE criteria, or if a spot simply looks different from last month, contact a dermatologist. If you are unsure where to start, DermaDex's contact page can connect you with a triage specialist.
How is melanoma treated?
Short answer: Surgical excision is the primary treatment for early-stage melanoma. Advanced melanoma may require immunotherapy, targeted therapy, radiation, or a combination, depending on tumor thickness, lymph node involvement, and whether the tumor carries a BRAF mutation. Stage at diagnosis is the single most important factor determining a patient's outcome, which is why monthly self-checks using the ABCDE rule matter.
Stage at diagnosis determines outcomes more than almost any other factor. The National Institutes of Health (NIH) / National Cancer Institute reports 5-year survival rates above 98% for localized (Stage I) melanoma, dropping to roughly 30% for distant (Stage IV) disease. This gap makes early detection through tools like the ABCDE rule a meaningful clinical intervention. For Stage I and II melanoma, surgeons remove the tumor with clear margins; excision width depends on tumor thickness as measured by Breslow depth. Sentinel lymph node biopsy may be performed for tumors thicker than 0.8 mm. For Stage III disease with lymph node involvement, adjuvant immunotherapy with checkpoint inhibitors such as pembrolizumab or nivolumab is now standard. Stage IV treatment has improved substantially since BRAF-targeted therapies became available for patients whose tumors carry the BRAF V600 mutation, which accounts for about 50% of cutaneous melanomas. Protecting your skin before melanoma develops remains the most effective strategy. Use a broad-spectrum sunscreen with a sun protection factor (SPF) of 30 or higher, wear protective clothing, and avoid peak UV hours between 10 AM and 4 PM.
Sources
- American Academy of Dermatology (AAD). "Melanoma skin cancer types." https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma (accessed August 2024).
- World Health Organization (WHO). "Ultraviolet radiation fact sheet." https://www.who.int/news-room/fact-sheets/detail/ultraviolet-radiation (accessed August 2024).
- National Cancer Institute. "Melanoma Treatment (PDQ) - Patient Version." https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq (accessed August 2024).
- PubMed / NCBI. Curtin JA et al. "Distinct sets of genetic alterations in melanoma." N Engl J Med. 2005;353(20):2135-2147. https://pubmed.ncbi.nlm.nih.gov/16291983/ (accessed August 2024).
- Statistics Canada. "Cancer in Canada." https://www.statcan.gc.ca/en/subjects-start/health (accessed August 2024).
- Centers for Disease Control and Prevention (CDC). "Skin Cancer Basics." https://www.cdc.gov/skin-cancer/about/index.html (accessed August 2024).
- Canadian Dermatology Association (CDA). Patient education resources. https://dermatology.ca (accessed August 2024).